Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
79.47
+2.66 (3.46%)
At close: Oct 16, 2025, 4:00 PM EDT
78.00
-1.47 (-1.85%)
Pre-market: Oct 17, 2025, 8:02 AM EDT

Corcept Therapeutics Revenue

Corcept Therapeutics had revenue of $194.43M in the quarter ending June 30, 2025, with 18.70% growth. This brings the company's revenue in the last twelve months to $716.08M, up 25.71% year-over-year. In the year 2024, Corcept Therapeutics had annual revenue of $675.04M with 39.94% growth.

Revenue (ttm)
$716.08M
Revenue Growth
+25.71%
P/S Ratio
11.52
Revenue / Employee
$1,432,160
Employees
500
Market Cap
8.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024675.04M192.67M39.94%
Dec 31, 2023482.38M80.52M20.04%
Dec 31, 2022401.86M35.88M9.80%
Dec 31, 2021365.98M12.10M3.42%
Dec 31, 2020353.87M47.39M15.46%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro